Nemolizumab (Nemluvio, Galderma) Shows Sustained Improvements in Itch and Lesions in PN June 18, 2025
Spotlight on Briquilimab in CIndU: Jasper’s Anti-CD117 Monoclonal Antibody Shows Safety and Efficacy in Phase 1b/2a Study June 16, 2025